# Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

Study · id `cardio:ct-nct03473223` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03473223](<https://clinicaltrials.gov/study/NCT03473223>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03473223

Browse, organ or system: Heart; Blood vessels; Brain  
Browse, condition area: High blood pressure; Coronary and vascular disease; Stroke; Heart rhythm problems; Heart failure; Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 18226 participants.

## Technical summary

Registry record NCT03473223. Randomized; quadruple masking; primary purpose prevention. Start 2018-03-21 (actual); primary completion 2023-02-16 (actual). Results posted on 2025-01-14.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 18226 participants (enrolled count; ClinicalTrials.gov record NCT03473223, source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)
- Started: 2018-03-21 (actual) (ClinicalTrials.gov record NCT03473223, source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)
- Primary completion: 2023-02-16 (actual) (ClinicalTrials.gov record NCT03473223, source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)
- Completion: 2023-11-17 (actual) (ClinicalTrials.gov record NCT03473223, source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)
- Results first posted: 2025-01-14 (ClinicalTrials.gov record NCT03473223, source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)
- Countries: United States; Argentina; Australia; Austria; Belgium; Brazil; Bulgaria; Canada; Chile; Colombia; Croatia; Czechia; Denmark; Estonia; Finland; France; Georgia; Germany; Greece; Hong Kong SAR China; Hungary; Israel; Italy; Japan; Latvia; Lithuania; Malaysia; Mexico; Netherlands; New Zealand; Norway; Peru; Poland; Portugal; Romania; Russia; Serbia; Singapore; Slovakia; South Africa; South Korea; Spain; Sweden; Switzerland; Taiwan; Thailand; Türkiye; Ukraine; United Kingdom (ClinicalTrials.gov record NCT03473223, source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03473223-2025-01-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
- Acronym: AEGIS-II
- Condition: Acute Coronary Syndrome
- Intervention (Biological): Apolipoprotein A-I \[human\] (apoA-I)
- Intervention (Other): Placebo
- Lead sponsor: CSL Behring
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: CSL Behring (`cardio:org-csl-behring`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial (`cardio:pubmed-39230545`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial (`cardio:pubmed-39221651`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 09e09775ea5c48486377f75161b13059a57364db27aa1c8c72518383e6f638bd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
